Novel vaccine targets inflamed brain cells in Alzheimer’s to modify the course of disease

FHS
July 31, 2023
11:52 am

A novel vaccine that targets inflamed brain cells associated with Alzheimer’s disease may hold the key to potentially preventing or modifying the course of the disease, according to preliminary research presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions 2023.

Investors anticipate “bounce-back” in European private investment – Pharmaceutical Technology

Share this article At the Swiss Biotech Day conference, experts anticipated a recovery in the investment market. Credit: Scharvik via Getty Images The Swiss biotech

April 26, 2024

Scoop: Metagenomi is preparing for an IPO this fall, in what could jumpstart a wave of public offerings

Gene-editing biotech Metagenomi is preparing to go public and is working with the investment bank JP Morgan on a potential listing this fall, according to

August 31, 2023

Nuclear Regulatory Commission advisers beset by conflicts of interest, report finds

The oversight division of a U.S. government agency tasked with ensuring the safe use of radioactive materials issued a recent report that the agency’s advisers

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.